A potent marker that allows the discrimination of inflammatory CD1c-CD11c+ DCs from resident CD1c+CD11c+ DCs in patients with psoriasis is TNF-related apoptosis-inducing ligand (TRAIL)31. The gene discussed is CD1C; the disease is psoriasis.